Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 205M | 181M | 163M | 151M | 142M | 133M |
| Cost of revenue | 127M | 109M | 97M | 95M | 86M | 80M |
| Gross profit | 78M | 72M | 65M | 56M | 56M | 53M |
| Research and development | 11M | 13M | 11M | 11M | 9M | 10M |
| Selling, general and administrative | 21M | 19M | 17M | 17M | 16M | 16M |
| Operating expenses | 84M | 83M | 75M | 72M | 67M | 68M |
| Operating income | −5M | −11M | −10M | −15M | −11M | −15M |
| Interest expense | 1M | 1M | 1M | 1M | 1M | 1M |
| Pre-tax income | −5M | −12M | −26M | −15M | −10M | −14M |
| Income tax | 248,000 | −17,000 | −8,000 | 0 | 30,000 | −10,000 |
| Net income | −5M | −12M | −26M | −15M | −10M | −14M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21M | 15M | 21M | 17M | 16M | 22M | 17M | 22M |
| Short-term investments | 203M | 204M | 204M | 209M | 216M | 218M | 217M | 219M |
| Receivables | 120M | 97M | 99M | 87M | 86M | 74M | 79M | 71M |
| Inventory | 4M | 4M | 4M | 5M | 4M | 4M | 4M | 3M |
| Current assets | 364M | 335M | 341M | 329M | 335M | 328M | 326M | 327M |
| Property, plant and equipment | 69M | 61M | 55M | 51M | 47M | 45M | 42M | 40M |
| Goodwill | 264M | 264M | 264M | 264M | 263M | 263M | 263M | 263M |
| Total assets | 740M | 704M | 699M | 687M | 690M | 680M | 678M | 679M |
| Current liabilities | 204M | 89M | 94M | 84M | 89M | 75M | 71M | 71M |
| Total liabilities | 457M | 427M | 426M | 416M | 379M | 365M | 362M | 362M |
| Equity | 282M | 276M | 272M | 272M | 311M | 314M | 316M | 317M |
| Treasury shares | 220,994 | 220,994 | 220,994 | 220,994 | — | 0 | — | — |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 15M | — | — | −4M | — | — |
| Depreciation and amortisation | 5M | 5M | 4M | 4M | 3M | 3M |
| Share-based compensation | 8M | 11M | 8M | 7M | 7M | 8M |
| Capital expenditure | — | — | — | 5M | — | — |
| Investing cash flow | −9M | — | — | −4M | — | — |
| Financing cash flow | 830,000 | — | — | 510,000 | — | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator